All Stories

  1. A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors

    Article • PLoS ONE, May 2024, PLOS

    Dr Ioannis Psallidas

  2. Effect of COVID-19 on Bronchiectasis Exacerbation Rates: A Retrospective U.S. Insurance Claims Study

    Article • Annals of the American Thoracic Society, February 2024, American Thoracic Society

    Dr Ioannis Psallidas

  3. Clinical identification of malignant pleural effusions

    Article • Translational Oncology, January 2024, Elsevier

    Dr Ioannis Psallidas

  4. Benralizumab increases time to recurrent exacerbations in COPD patients on triple therapy with frequent exacerbations and an eosinophilic phenotype

    Article • September 2023, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  5. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2023, Taylor & Francis

    Dr Ioannis Psallidas

  6. Effect of COVID-19 on non-cystic fibrosis bronchiectasis exacerbation rates: a retrospective claims study

    Article • September 2022, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  7. The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing

    Article • The Lancet Microbe, April 2022, Elsevier

    Dr Ioannis Psallidas

  8. Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial

    Article • The Lancet Respiratory Medicine, February 2022, Elsevier

    Dr Ioannis Psallidas

  9. KRAS signaling in malignant pleural mesothelioma

    Article • EMBO Molecular Medicine, December 2021, EMBO

    Dr Ioannis Psallidas

  10. Characterization of Clinical Absorption, Distribution, Metabolism, and Excretion and Pharmacokinetics of Velsecorat Using an Intravenous Microtracer Combined with an Inhaled Dose in Healthy Subjects

    Article • Drug Metabolism and Disposition, December 2021, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Ioannis Psallidas

  11. The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma

    Article • CHEST Journal, November 2021, Elsevier

    Dr Ioannis Psallidas

  12. Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases

    Article • Journal of Thoracic Oncology, October 2021, Elsevier

    Dr Ioannis Psallidas

  13. The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD

    Article • European Respiratory Journal, September 2021, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  14. Thoracic Ultrasound for guiding pleurodesis in malignant pleural effusion: a randomised trial

    Article • September 2021, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  15. Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation

    Article • Frontiers in Oncology, April 2021, Frontiers

    Dr Ioannis Psallidas

  16. A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma

    Article • American Journal of Respiratory and Critical Care Medicine, February 2021, American Thoracic Society

    Dr Ioannis Psallidas

  17. S46 Identification of pleural infection bacterial patterns. The oxford pleural infection metagenomics study

    Article • January 2021, BMJ

    Dr Ioannis Psallidas

  18. “Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study.” John P. Corcoran, Ioannis Psallidas, Stephen Gerry, Francesco Piccolo, Coenraad F. Koegelenberg, Tarek Saba, Cyrus Daneshvar...

    Article • European Respiratory Journal, December 2020, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  19. Management of Indwelling Tunneled Pleural Catheters

    Article • CHEST Journal, November 2020, Elsevier

    Dr Ioannis Psallidas

  20. Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments

    Article • Thorax, September 2020, BMJ

    Dr Ioannis Psallidas

  21. Application of machine learning algorithms to predict loss of asthma control: A post-hoc analysis of INCONTRO study

    Article • September 2020, European Respiratory Society (ERS)

    Sofia Necander, Dr Ioannis Psallidas

  22. Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis

    Article • September 2020, European Respiratory Society (ERS)

    Robert Palmér, Dr Ioannis Psallidas

  23. Correlation between clinic and remote FEV1 and FeNO measurements; post hoc analysis of the INCONTRO study

    Article • September 2020, European Respiratory Society (ERS)

    Sofia Necander, Dr Ioannis Psallidas

  24. The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients

    Article • September 2020, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  25. Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro

    Article • September 2020, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  26. Identification of pleural infection microbiological patterns by applying next generation sequencing and bioinformatics analysis

    Article • September 2020, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  27. Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies

    Article • September 2020, Springer Science + Business Media

    Dr Ioannis Psallidas

  28. Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator

    Article • September 2020, Springer Science + Business Media

    Dr Ioannis Psallidas

  29. Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology...

    Article • September 2020, Springer Science + Business Media

    Dr Ioannis Psallidas

  30. Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    Najib Rahman, Dr Ioannis Psallidas

  31. Clinical identification of malignant pleural effusions

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Dr Ioannis Psallidas

  32. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  33. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

    Article • European Journal of Cardio-Thoracic Surgery, May 2020, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  34. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions

    Article • JAMA, January 2020, American Medical Association (AMA)

    Dr Ioannis Psallidas

  35. Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set

    Article • Respirology, December 2019, Wiley

    Dr Ioannis Psallidas

  36. Osteopontin drives KRAS-mutant lung adenocarcinoma

    Article • Carcinogenesis, November 2019, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  37. S13 The microbiology of pleural infection, an approach based on 16s RRNA gene next generation sequencing

    Article • November 2019, BMJ

    Dr Ioannis Psallidas

  38. Survival in patients with malignant pleural effusion undergoing talc pleurodesis

    Article • Lung Cancer, November 2019, Elsevier

    Dr Ioannis Psallidas

  39. Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients

    Article • BMJ Open Respiratory Research, September 2019, BMJ

    Dr Ioannis Psallidas

  40. Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight

    Article • Cells, August 2019, MDPI AG

    Dr Ioannis Psallidas

  41. The microbiology of pleural infection in adults: a systematic review

    Article • European Respiratory Journal, June 2019, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  42. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial

    Article • European Respiratory Journal, May 2019, European Respiratory Society (ERS)

    Najib Rahman, Erika Penz, Dr Ioannis Psallidas

  43. A Randomized Trial of Dual-Acting Bronchodilator AZD8871 for Chronic Obstructive Pulmonary Disease

    Article • American Journal of Respiratory and Critical Care Medicine, May 2019, American Thoracic Society

    Dr Ioannis Psallidas

  44. A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial with Withdrawal Design of AZD1419, a Toll-9 Agonist in Adults with Eosinophilic, Moderate to Severe Asthma

    Article • May 2019, American Thoracic Society

    Dr Ioannis Psallidas

  45. Interpreting pleural fluid results

    Article • Clinical Medicine, May 2019, Elsevier

    Dr Ioannis Psallidas

  46. Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial

    Article • The Lancet Respiratory Medicine, May 2019, Elsevier

    Dr Ioannis Psallidas

  47. Novel mouse model of indwelling pleural catheter in mice with malignant pleural effusion

    Article • ERJ Open Research, April 2019, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  48. Tobacco chemical-induced mouse lung adenocarcinoma cell lines pin the prolactin orthologue proliferin as a lung tumour promoter

    Article • Carcinogenesis, March 2019, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  49. Palliative care in mesothelioma: Are current services RESPECT-able enough?

    Article • Thorax, March 2019, BMJ

    Dr Ioannis Psallidas

  50. Response

    Article • CHEST Journal, March 2019, Elsevier

    Dr Ioannis Psallidas

  51. Does attempting talc pleurodesis affect subsequent indwelling pleural catheter (IPC)-related non-draining septated pleural effusion and IPC-related spontaneous pleurodesis?

    Article • ERJ Open Research, February 2019, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  52. Prospective Analysis of the Predictive Value of Sonographic Pleural Fluid Echogenicity for the Diagnosis of Exudative Effusion

    Article • Respiration, January 2019, Karger Publishers

    Dr Ioannis Psallidas

  53. S133 Breathlessness post-drainage predicts survival in patients with malignant pleural effusion

    Article • November 2018, BMJ

    Dr Ioannis Psallidas

  54. S130 Human mesothelioma cell lines developed from malignant pleural effusions as tools to develop novel therapies and guide personalised medicine

    Article • November 2018, BMJ

    Dr Ioannis Psallidas

  55. P257 Is mesothelioma associated with increased risk of indwelling pleural catheter-related septated pleural effusion?

    Article • November 2018, BMJ

    Dr Ioannis Psallidas

  56. S131 Novel model of indwelling pleural catheter in mice with malignant pleural effusion

    Article • November 2018, BMJ

    Dr Ioannis Psallidas

  57. P258 Retrospective analysis of whether prior talc pleurodesis attempt affects subsequent IPC-related autopleurodesis or not

    Article • November 2018, BMJ

    Dr Ioannis Psallidas

  58. P260 The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients

    Article • November 2018, BMJ

    Dr Ioannis Psallidas

  59. Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion

    Article • CHEST Journal, November 2018, Elsevier

    Dr Ioannis Psallidas

  60. A Pilot Feasibility Study in Establishing the Role of Ultrasound-Guided Pleural Biopsies in Pleural Infection (The AUDIO Study)

    Article • CHEST Journal, October 2018, Elsevier

    Dr Ioannis Psallidas

  61. Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations

    Article • Translational Lung Cancer Research, October 2018, AME Publishing Company

    Dr Ioannis Psallidas

  62. The Hospital and Patient Burden of Indwelling Pleural Catheters: A Retrospective Case Series of 210 Indwelling Pleural Catheter Insertions

    Article • Respiration, September 2018, Karger Publishers

    Dr Ioannis Psallidas

  63. Pharmacodynamic and pharmacokinetic results after repeated doses of AZD8871 in COPD patients

    Article • September 2018, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  64. Does the sonographic presence and severity of pleural fluid septation have an impact on clinical outcomes in pleural infection? - Data from the Pleural Infection Longitudinal Outcome Study (PILOT)

    Article • September 2018, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  65. Does talc increase risk of non-draining septated pleural effusion after indwelling pleural catheter insertion?

    Article • September 2018, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  66. Predictors of pleurodesis success

    Article • September 2018, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  67. The patient perspective of treatment for Malignant Pleural Effusion (MPE)- results of a pilot service-evaluation questionnaire.

    Article • September 2018, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  68. The biological effect of intrapleural tissue plasminogen (tPA) activator and DNase delivery in pleural infection patients

    Article • September 2018, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  69. Multiple ascending inhaled doses of AZD8871 in healthy males

    Article • September 2018, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  70. Activity and Outcomes From a Dedicated Pleural On-Call Service

    Article • CHEST Journal, September 2018, Elsevier

    Dr Ioannis Psallidas

  71. Providing safe and effective pleural medicine services in the UK: an aspirational statement from UK pleural physicians

    Article • BMJ Open Respiratory Research, August 2018, BMJ

    Dr Ioannis Psallidas

  72. ERS/EACTS statement on the management of malignant pleural effusions

    Article • European Journal of Cardio-Thoracic Surgery, July 2018, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  73. ERS/EACTS statement on the management of malignant pleural effusions

    Article • European Respiratory Journal, July 2018, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  74. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis

    Article • The Lancet Oncology, July 2018, Elsevier

    Dr Ioannis Psallidas

  75. Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2018, New England Journal of Medicine (NEJM/MMS)

    Dr Ioannis Psallidas

  76. Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion

    Article • American Journal of Respiratory and Critical Care Medicine, February 2018, American Thoracic Society

    Najib Rahman, Dr Ioannis Psallidas

  77. Chest drain size: Does it matter?

    Article • Eurasian Journal of Pulmonology, January 2018, Kare Publishing

    Dr Ioannis Psallidas

  78. Preliminary results of the Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study

    Article • Lung Cancer, January 2018, Elsevier

    Dr Ioannis Psallidas

  79. S24 A phase i feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (the audio study)

    Article • November 2017, BMJ

    Dr Ioannis Psallidas

  80. S129 Does inflammation predict successful pleurodesis? a post hoc analysis from the time 1 trial

    Article • November 2017, BMJ

    Dr Ioannis Psallidas

  81. S128 Exploring the behaviour of mesothelioma in a post hoc analysis from the time 1 trial

    Article • November 2017, BMJ

    Dr Ioannis Psallidas

  82. P239 Is a pleural on-call service beneficial?

    Article • November 2017, BMJ

    Dr Ioannis Psallidas

  83. P234 Patient and fluid characteristics associated with non-draining malignant pleural effusion

    Article • November 2017, BMJ

    Dr Ioannis Psallidas

  84. P233 Thoracic ultrasonography as a predictor of pleurodesis success in malignant pleural effusion

    Article • November 2017, BMJ

    Dr Ioannis Psallidas

  85. Thoracic involvement in IgG4-related disease in a UK-based patient cohort

    Article • Respiratory Medicine, November 2017, Elsevier

    Dr Ioannis Psallidas

  86. Late Breaking Abstract - A phase I feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (The AUDIO study)

    Article • September 2017, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  87. Late Breaking Abstract - Prognostic and therapeutic markers of malignant pleural effusion – The PROMISE study

    Article • September 2017, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  88. Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion

    Article • September 2017, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  89. Case series to analyse whether echogenicity always reveals underlying exudate or not

    Article • September 2017, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  90. LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes

    Article • September 2017, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  91. Respiratory training in Greece

    Article • Breathe, August 2017, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  92. Pleural Diseases: Saline Irrigation in Pleural Infection, Epidemiology of Pneumothorax, and Bevacizumab in Mesothelioma

    Article • American Journal of Respiratory and Critical Care Medicine, August 2017, American Thoracic Society

    Najib Rahman, Dr Ioannis Psallidas

  93. Treatment of limited disease small cell lung cancer: the multidisciplinary team

    Article • European Respiratory Journal, August 2017, European Respiratory Society (ERS)

    Prof. Dr. Isabelle Opitz, Dr Ioannis Psallidas

  94. Assessment of patient-reported outcome measures in pleural interventions

    Article • BMJ Open Respiratory Research, July 2017, BMJ

    Dr Ioannis Psallidas

  95. Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

    Article • EMBO Molecular Medicine, June 2017, EMBO

    Dr Ioannis Psallidas

  96. Management of malignant pleural effusion: challenges and solutions

    Article • Cancer Management and Research, June 2017, Dove Medical Press

    Erika Penz, Dr Ioannis Psallidas

  97. Mutant KRAS promotes malignant pleural effusion formation

    Article • Nature Communications, May 2017, Springer Science + Business Media

    Dr Ioannis Psallidas

  98. NRAS destines tumor cells to the lungs

    Article • EMBO Molecular Medicine, March 2017, Springer Science + Business Media

    Dr Ioannis Psallidas

  99. Ultrasound in the management of pleural disease

    Article • Expert Review of Respiratory Medicine, March 2017, Taylor & Francis

    Najib Rahman, Dr Ioannis Psallidas

  100. Provision of Day-Case Local Anesthetic Thoracoscopy

    Article • CHEST Journal, February 2017, Elsevier

    Dr Ioannis Psallidas

  101. Chest Drain Size: the Debate Continues

    Article • Current Pulmonology Reports, January 2017, Springer Science + Business Media

    Dr Ioannis Psallidas

  102. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment

    Article • European Respiratory Review, November 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  103. P4 A prospective assessment of the clinical utility of intercostal artery identification in pleural intervention

    Article • Thorax, November 2016, BMJ

    Dr Ioannis Psallidas

  104. S94 Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion

    Article • Thorax, November 2016, BMJ

    Dr Ioannis Psallidas

  105. P2 Incorporation of an in-depth thoracic ultrasound assessment into routine pre-procedural evaluation of patients with pleural effusions

    Article • Thorax, November 2016, BMJ

    Dr Ioannis Psallidas

  106. S7 Mouse lung adenocarcinoma cell lines reveal PRL2C2 as a novel lung tumour promoter

    Article • Thorax, November 2016, BMJ

    Dr Ioannis Psallidas

  107. S8 Osteopontin as an airway epithelial tumour promoter

    Article • Thorax, November 2016, BMJ

    Dr Ioannis Psallidas

  108. Effectiveness of chemical pleurodesis in spontaneous pneumothorax recurrence prevention: a systematic review

    Article • Thorax, November 2016, BMJ

    Dr Ioannis Psallidas

  109. Biological markers of successful pleurodesis for malignant pleural effusion

    Article • September 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  110. Long-term outcome of patients with non-specific pleuritis on thoracoscopic or ultrasound-guided pleural biopsies

    Article • September 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  111. Lent score validation on patients with malignant pleural effusion

    Article • September 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  112. LSC Abstract – Osteopontin as an airway epithelial tumor promoter

    Article • September 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  113. “Advanced medical interventions in pleural disease.” Rahul Bhatnagar, John P. Corcoran, Fabien Maldonado, David Feller-Kopman, Julius Janssen, Philippe Astoul and Najib M. Rahman. Eur Respir Rev 2016; 25: 199–213.

    Article • European Respiratory Review, August 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  114. Landmark studies for targeted treatments in lung cancer

    Article • Breathe, June 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas, Dr Tiago Jacinto

  115. Advances in pleural disease

    Article • European Respiratory Review, May 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  116. Malignant pleural effusion: from bench to bedside

    Article • European Respiratory Review, May 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  117. Safe site selection for chest drain insertion by trainee physicians — Implications for medical training and clinical practice

    Article • European Journal of Internal Medicine, March 2016, Elsevier

    Dr Ioannis Psallidas

  118. Always Worth Another Look? Thoracic Ultrasonography before, during, and after Pleural Intervention

    Article • Annals of the American Thoracic Society, January 2016, American Thoracic Society

    Dr Ioannis Psallidas

  119. 30 Patient experience of a telephone nodule follow-up clinic

    Article • Lung Cancer, January 2016, Elsevier

    Dr Ioannis Psallidas

  120. Medical thoracoscopy: Survey of current practice-How successful are medical thoracoscopists at predicting malignancy?

    Article • Respirology, December 2015, Wiley

    Dr Ioannis Psallidas

  121. Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion

    Article • JAMA, December 2015, American Medical Association (AMA)

    Dr Ioannis Psallidas

  122. S20 Primary Result of the 1st Therapeutic Interventions in Malignant Effusion (TIME1) Trial: A 2 × 2 factorial, randomised trial of chest tube size and analgesic strategy for pleurodesis in malignant pleural effusion

    Article • Thorax, November 2015, BMJ

    Dr Ioannis Psallidas

  123. P179 The Effectiveness of Chemical Pleurodesis Agents in Spontaneous Pneumothorax: A Systematic Review: Abstract P179 Table 1

    Article • Thorax, November 2015, BMJ

    Dr Ioannis Psallidas

  124. P207 Thoracic involvement in IgG4-related disease

    Article • Thorax, November 2015, BMJ

    Dr Ioannis Psallidas

  125. Diagnostic value of radiological imaging pre‐ and post‐drainage of pleural effusions

    Article • Respirology, November 2015, Wiley

    Dr Ioannis Psallidas

  126. Draining pleural effusions before radiological imaging does not improve diagnostic capability

    Article • September 2015, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  127. Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification

    Article • September 2015, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  128. Patient-related outcome measurements in pleural diseases

    Article • September 2015, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  129. LSC Abstract – A requirement for mast cells in malignant pleural effusion

    Article • September 2015, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  130. Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growthin vivo

    Article • Respirology, August 2015, Wiley

    Dr Ioannis Psallidas

  131. Individualised management of malignant pleural effusion

    Article • The Lancet Respiratory Medicine, July 2015, Elsevier

    Dr Ioannis Psallidas

  132. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection

    Article • CHEST Journal, July 2015, Elsevier

    Dr Ioannis Psallidas

  133. Iatrogenic injury to the intercostal artery: aetiology, diagnosis and therapeutic intervention

    Article • Thorax, April 2015, BMJ

    Dr Ioannis Psallidas

  134. Mast cells mediate malignant pleural effusion formation

    Article • Journal of Clinical Investigation, April 2015, American Society for Clinical Investigation

    Dr Ioannis Psallidas

  135. Intercostal chest drain insertion by general physicians: attitudes, experience and implications for training, service and patient safety

    Article • Postgraduate Medical Journal, April 2015, BMJ

    Dr Ioannis Psallidas

  136. Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence

    Article • Infectious Diseases, March 2015, Taylor & Francis

    Dr Ioannis Psallidas

  137. Ultrasound-guided pneumothorax induction prior to local anaesthetic thoracoscopy: Table 1

    Article • Thorax, February 2015, BMJ

    Dr Ioannis Psallidas

  138. A 63-year-old man with a recurrent right-sided pleural effusion: Figure 1

    Article • Thorax, January 2015, BMJ

    Dr Ioannis Psallidas

  139. Management of Parapneumonic Effusions and Empyema

    Article • Seminars in Respiratory and Critical Care Medicine, December 2014, Thieme Publishing Group

    Dr Ioannis Psallidas

  140. P175 Measurement Of Air Leak Post-thoracic Surgery: Implications For Medical Management Of Pneumothorax

    Article • Thorax, November 2014, BMJ

    Dr Ioannis Psallidas

  141. S45 How Successful Are Medical Thoracoscopists At Predicting Malignancy?

    Article • Thorax, November 2014, BMJ

    Dr Ioannis Psallidas

  142. S40 Improving The Patient Journey: Thoracic Ultrasonography As An Adjunct To Decision Making And Diagnostic Pathways In Pleural Disease

    Article • Thorax, November 2014, BMJ

    Dr Ioannis Psallidas

  143. P177 Patient-related Outcome Measurements In Pleural Effusions

    Article • Thorax, November 2014, BMJ

    Dr Ioannis Psallidas

  144. P111 Procedural Experience, Training Opportunities And Attitudes Towards Intercostal Chest Drain Insertion: Variations Between Consultants, Trainees And Medical Sub-specialties

    Article • Thorax, November 2014, BMJ

    Dr Ioannis Psallidas

  145. S117 Survival In Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From 6 Uk Centres

    Article • Thorax, November 2014, BMJ

    Dr Ioannis Psallidas

  146. Tuberculous pleuritis secondary toMycobacterium bovisin a veterinarian

    Article • The Clinical Respiratory Journal, November 2014, Wiley

    Dr Ioannis Psallidas

  147. Physician-Based Ultrasound-Guided Biopsy for Diagnosing Pleural Disease

    Article • CHEST Journal, October 2014, Elsevier

    Dr Ioannis Psallidas

  148. Image of the month: A misleading chest X-ray - not all opacification is effusion

    Article • Clinical Medicine, October 2014, Royal College of Physicians

    Dr Ioannis Psallidas

  149. Staphylococcus aureusbio-products: New biological roles for a pleurodesis agent

    Article • Respirology, August 2014, Wiley

    Dr Ioannis Psallidas

  150. Reexpansion Pulmonary Edema Following Local Anesthetic Thoracoscopy

    Article • CHEST Journal, August 2014, Elsevier

    Dr Ioannis Psallidas

  151. Paracetamol and ibuprofen block hydrothorax absorption in mice

    Article • European Journal of Cardio-Thoracic Surgery, June 2014, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  152. Interleukin-18 is up-regulated in infectious pleural effusions

    Article • Cytokine, August 2013, Elsevier

    Dr Nikoletta Rovina, Dr Ioannis Psallidas

  153. Interleukin‐17A is involved in bacteria‐related acute pleural inflammation

    Article • Respirology, March 2013, Wiley

    Dr Ioannis Psallidas

  154. Inhibition Of Osteopontin Modulates Tumor-Stimulated Immune Response And Suppresses Mesothelioma Progression

    Article • May 2012, American Thoracic Society

    Dr Ioannis Psallidas

  155. Abstract 2873: Opposing effects of NF-κB inhibition during chemical lung carcinogenesis

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Dr Ioannis Psallidas

  156. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion

    Article • Oncogene, February 2012, Nature

    Dr Ioannis Psallidas

  157. Opposing effects of bortezomib-induced nuclear factor- B inhibition on chemical lung carcinogenesis

    Article • Carcinogenesis, January 2012, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  158. Neutralization of Tumor Necrosis Factor Bioactivity Ameliorates Urethane-Induced Pulmonary Oncogenesis in Mice

    Article • Neoplasia, December 2011, Elsevier

    Dr Ioannis Psallidas

  159. A sulindac analogue is effective against malignant pleural effusion in mice

    Article • Lung Cancer, August 2011, Elsevier

    Dr Ioannis Psallidas

  160. Static and dynamic mechanics of the murine lung after intratracheal bleomycin

    Article • BMC Pulmonary Medicine, January 2011, Springer Science + Business Media

    Dr Ioannis Psallidas

  161. Secreted Phosphoprotein-1 Enhances Urethane-induced Lung Carcinogenesis

    Article • May 2010, American Thoracic Society

    Dr Ioannis Psallidas

  162. Osteopontin Is Important For Malignant Pleural Effusion Formation

    Article • May 2010, American Thoracic Society

    Dr Ioannis Psallidas

  163. Dexamethasone acutely accelerates pleural fluid absorption in mice hydrothoraces

    Article • The Journal of Physiological Sciences, April 2010, Springer Science + Business Media

    Dr Ioannis Psallidas

  164. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study

    Article • Molecular Cancer, January 2010, Springer Science + Business Media

    Dr Ioannis Psallidas

  165. Protective Effects of Mastic Oil FromPistacia LentiscusVariationChiaAgainst Experimental Growth of Lewis Lung Carcinoma

    Article • Nutrition and Cancer, September 2009, Taylor & Francis

    Dr Ioannis Psallidas

  166. Osteopontin is upregulated in malignant and inflammatory pleural effusions

    Article • Respirology, July 2009, Wiley

    Dr Ioannis Psallidas

  167. Etanercept-induced pleuropericardial lupus-like syndrome

    Article • European Respiratory Journal, April 2009, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  168. The Angiopoietin/Tie2 Axis Mediates Malignant Pleural Effusion Formation

    Article • Neoplasia, March 2009, Elsevier

    Dr Ioannis Psallidas

  169. A Central Role for Tumor-derived Monocyte Chemoattractant Protein-1 in Malignant Pleural Effusion

    Article • JNCI Journal of the National Cancer Institute, October 2008, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  170. Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion

    Article • American Journal of Respiratory and Critical Care Medicine, July 2008, American Thoracic Society

    Dr Ioannis Psallidas

  171. Tumor Necrosis Factor-  Promotes Malignant Pleural Effusion

    Article • Cancer Research, October 2007, American Association for Cancer Research (AACR)

    Dr Ioannis Psallidas

  172. The efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE)

    Article • Springer Science + Business Media

    Dr Ioannis Psallidas